Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Nature Communications|August 11, 2022
The causes and consequences of Alzheimer's disease: phenome-wide evidence from Mendelian randomizationRoxanna Korologou-Linden, Laxmi Bhatta, Ben M Brumpton, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 21, 2018
A Frailty Index for UK Biobank ParticipantsDylan M Williams, Juulia Jylhävä, Nancy L Pedersen, et al.
Neurology|December 29, 2017
Circulating insulin-like growth factors and Alzheimer disease: A mendelian randomization studyDylan M Williams, Ida K Karlsson, Nancy L Pedersen, et al.
Plos Genetics|July 14, 2022
Polygenic and socioeconomic risk for high body mass index: 69 years of follow-up across lifeDavid Bann, Liam Wright, Rebecca Hardy, et al.
Annals of Neurology|November 13, 2019
Lipid lowering and Alzheimer disease risk: A mendelian randomization studyDylan M Williams, Chris Finan, Amand F Schmidt, et al.
Annals of Neurology|August 26, 2020
Evaluating Lipid-Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian RandomizationDylan M Williams, Sara Bandres-Ciga, Karl Heilbron, et al.
Wellcome Open Research|January 29, 2019
Metabolic profiling of adolescent non-alcoholic fatty liver diseaseApril Hartley, Diana L Santos Ferreira, Emma L Anderson, et al.
Brain, Behavior, & Immunity - Health|February 16, 2026
Assessing the repurposing potential of disease-modifying antirheumatic drug targets to reduce Alzheimer's disease risk: a Mendelian randomization studyChristina N Kushnir, Victoria Taylor-Bateman, Neil M Davies, et al.
Pageof 11